Scientists Unveil Consensus Framework to Standardize Non-Pharmacological Intervention Research

From mindfulness programs and exercise regimens to cognitive training and dietary counseling, non-pharmacological interventions have become a cornerstone of modern prevention and care. Yet unlike medicines, which pass through universally recognized stages of laboratory testing, clinical trials, and regulatory review, these interventions have long lacked a shared evaluation framework. A new study published in Health Research Policy and Systems now proposes a remedy. An international team led by Gregory Ninot of the University of Montpellier and Arnaud Legout of INRIA presents the NPIS Model, a consensus-based framework comprising 77 recommendations for evaluating non-pharmacological interventions across their entire research lifecycle. The work, developed with more than 500 stakeholders, aims to bring the same methodological discipline to non-drug interventions that randomized trial standards and regulatory pathways have long provided for pharmaceuticals.

The problem the researchers set out to solve is deceptively simple to state but difficult to resolve. The term non-pharmacological intervention, or NPI, refers to health prevention and care protocols supervised by healthcare professionals, yet no precise and widely adopted definition currently exists. This definitional vacuum has real consequences. Because NPIs vary enormously in content, delivery, and study design, research findings are difficult to compare, replicate, or synthesize. The authors argue that this heterogeneity limits scientific impact, hinders dissemination and continuous improvement of practices, and contributes to significant mistrust among professionals and the public. Existing reporting guidelines such as CONSORT address only a subset of the study types relevant to NPI assessment, leaving large portions of the evidence base without shared standards.

To build the framework, the team conducted a structured consensus study from 2022 to 2023, collaborating with researchers, healthcare users, healthcare practitioners, health operators, scientific societies, and health authorities. The methodology was hybrid, primarily inspired by the Nominal Group Technique and supplemented with elements of a modified Delphi approach. A multidisciplinary committee of 22 experts guided the process through iterative, open, and documented exchanges across four stages. First, a committee of 70 members created an initial list of ethical and methodological items. Second, a larger committee of 300 members refined that list. Third, 503 voters cast open votes on each individual item. Finally, the draft framework was submitted for consultation to 36 scientific societies and 14 health authorities, whose feedback shaped the final document.

The consensus process yielded a definition that anchors the entire model. An NPI, the stakeholders agreed, is an evidence-based, effective, personalized, non-invasive health prevention or care protocol, registered and supervised by a qualified professional. Each element of this definition carries weight. The requirement of an evidence base excludes practices unsupported by research. The emphasis on personalization acknowledges that non-drug interventions are typically tailored to individual circumstances rather than administered in fixed doses. The non-invasive criterion distinguishes these protocols from surgical or otherwise intrusive procedures. Registration and professional supervision, meanwhile, address concerns about unregulated practitioners and unverified claims that have long shadowed the field.

On top of this definition, the researchers constructed the NPIS Model as a set of 77 recommendations for evaluating NPIs, divided into 14 ethical and 63 methodological items. Every recommendation achieved at least 80 percent agreement among voters, a threshold the authors describe as evidence of genuine consensus rather than mere majority preference. The recommendations are organized around five types of studies that together span the translational pathway of an intervention: mechanistic studies, which probe how an intervention works at biological or psychological levels; observational studies, which document associations in real-world populations; prototypical studies, which establish feasibility and preliminary signals; intervention studies, the controlled trials that test efficacy; and implementation studies, which examine how interventions perform when deployed at scale in routine care.

This five-stage architecture is one of the model’s most distinctive technical contributions. Traditional evaluation frameworks tend to privilege the randomized controlled trial as the gold standard, but the authors argue that NPIs require a broader evidentiary ecosystem. A mindfulness-based stress reduction program, for example, cannot be evaluated in the same way as a small-molecule drug. Its active ingredients are distributed across instructor competence, participant engagement, dose and frequency of practice, and the therapeutic relationship itself. Mechanistic work may be needed to identify which psychological or neurobiological pathways are engaged, while implementation research determines whether the program retains its benefits when delivered by ordinary clinicians in busy clinics rather than by the specialists who designed it.

The ethical recommendations embedded in the model are equally notable. Because NPIs often involve vulnerable populations, behavioral manipulation, and long-term lifestyle change, questions of informed consent, participant burden, data protection, and equitable access take on particular urgency. By codifying 14 ethical requirements alongside the methodological ones, the framework signals that rigor and ethics are inseparable in this field. The authors report that 31 scientific societies and three health authorities have already provided letters of support for the NPIS Model, suggesting substantial institutional appetite for a shared reference. The framework is also accompanied by a registry maintained by the Non-Pharmacological Intervention Society, the non-profit scientific organization that coordinated the consensus process.

The study’s authors are candid about the limitations of their work. Because the framework was developed by francophone contributors, with voting restricted to residents of France, its applicability beyond this setting remains to be established through future international consultation and validation. Health systems differ in financing, professional regulation, and cultural attitudes toward non-drug therapies, and a framework forged in one national context may require adaptation elsewhere. The researchers also disclose a non-financial competing interest: several team members hold founding, leadership, or coordinating roles within the Non-Pharmacological Intervention Society, the organization that created and promotes the model. Transparency about these constraints, they suggest, is itself consistent with the model’s ethos of open, documented consensus-building.

If the NPIS Model gains international traction, its implications could reach far beyond academic methodology. Insurers and health authorities increasingly face pressure to decide which non-drug therapies to reimburse, and the absence of shared evaluation standards has made those decisions contentious. A common framework could help distinguish well-supported interventions from poorly validated ones, protect patients from unproven claims, and give practitioners confidence that the protocols they adopt meet recognized ethical and scientific benchmarks. For researchers, the model offers a roadmap for designing studies that regulators, journals, and funders can readily assess. The authors hope the framework will promote transparency, methodological rigour, ethical standards, and transferability in NPI research, ultimately increasing the value of evaluation for researchers, practitioners, healthcare users, and health authorities alike. Whether the model achieves that ambition will depend on the international validation studies now needed to test its portability across borders and health systems.

Subject of Research: A consensus-based framework for evaluating non-pharmacological interventions in health prevention and care

Article Title: The NPIS model: a consensus-based framework for evaluating non-pharmacological interventions

Article References: Ninot, G., Descamps, E., Achalid, G., Abad, S., Carbonnel, F., Carrieri, P., Dargent-Molina, P., Fiteni, F., Foucaut, A.-M., Guyon, A., Legout, A., Lognos, B., Molinari, N., Nizard, J., Nogues, M., Poisbeau, P., Rochaix, L., & Falissard, B. (2026). The NPIS model: a consensus-based framework for evaluating non-pharmacological interventions. Health Research Policy and Systems. https://doi.org/10.1186/s12961-026-01521-1

Image Credits: AI Generated

DOI: 10.1186/s12961-026-01521-1

Keywords: non-pharmacological interventions, NPIS Model, consensus study, health research evaluation, research methodology, medical ethics, public health, Nominal Group Technique, Delphi method, clinical guidelines, evidence-based practice, health policy